Cite
Fiala EM, Jayakumaran G, Mauguen A, et al. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. Nat Cancer. 2021;2:357-365doi: 10.1038/s43018-021-00172-1.
Fiala, E. M., Jayakumaran, G., Mauguen, A., Kennedy, J. A., Bouvier, N., Kemel, Y., Fleischut, M. H., Maio, A., Salo-Mullen, E. E., Sheehan, M., Arnold, A. G., Latham, A., Carlo, M. I., Cadoo, K., Murkherjee, S., Slotkin, E. K., Trippett, T., Bender, J. G., Meyers, P. A., Wexler, L., Dela Cruz, F. S., Cheung, N. K., Basu, E., Kentsis, A., Ortiz, M., Francis, J. H., Dunkel, I. J., Khakoo, Y., Gilheeney, S., Sait, S. F., Forlenza, C. J., Sulis, M., Karajannis, M., Modak, S., Gerstle, J. T., Heaton, T. E., Roberts, S., Yang, C., Jairam, S., Vijai, J., Topka, S., Friedman, D. N., Stadler, Z. K., Robson, M., Berger, M. F., Schultz, N., Ladanyi, M., O'Reilly, R. J., Abramson, D. H., Ceyhan-Birsoy, O., Zhang, L., Mandelker, D., Shukla, N. N., Kung, A. L., Offit, K., Zehir, A., & Walsh, M. F. (2021). Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. Nature cancer, 2357-365. https://doi.org/10.1038/s43018-021-00172-1
Fiala, Elise M, et al. "Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors." Nature cancer vol. 2 (2021): 357-365. doi: https://doi.org/10.1038/s43018-021-00172-1
Fiala EM, Jayakumaran G, Mauguen A, Kennedy JA, Bouvier N, Kemel Y, Fleischut MH, Maio A, Salo-Mullen EE, Sheehan M, Arnold AG, Latham A, Carlo MI, Cadoo K, Murkherjee S, Slotkin EK, Trippett T, Bender JG, Meyers PA, Wexler L, Dela Cruz FS, Cheung NK, Basu E, Kentsis A, Ortiz M, Francis JH, Dunkel IJ, Khakoo Y, Gilheeney S, Sait SF, Forlenza CJ, Sulis M, Karajannis M, Modak S, Gerstle JT, Heaton TE, Roberts S, Yang C, Jairam S, Vijai J, Topka S, Friedman DN, Stadler ZK, Robson M, Berger MF, Schultz N, Ladanyi M, O'Reilly RJ, Abramson DH, Ceyhan-Birsoy O, Zhang L, Mandelker D, Shukla NN, Kung AL, Offit K, Zehir A, Walsh MF. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors. Nat Cancer. 2021 Mar;2:357-365. doi: 10.1038/s43018-021-00172-1. Epub 2021 Feb 15. PMID: 34308366; PMCID: PMC8294573.
Copy
Download .nbib